Ludwig Institut für Krebsforschung AG
Company Overview
Previous Company Names
- Ludwig Institut für Krebsforschung
- (Institut Ludwig de recherche sur le cancer) (Ludwig Institute for Cancer Research)
Management
Jonathan Skipper
Norwalk, US
Manager
Joint signing authority (any two to sign)
Barbara Jones
New York, US
Member of the board
Joint signing authority (any two to sign)
Thomas Bänninger
Brütten
Joint signing authority (any two to sign)
Nancy Davidson
Seattle, US
Member of the board
Joint signing authority (any two to sign)
Alexander Borissov
Herrliberg
Secretary (non-member of the board)
Joint signing authority (any two to sign)
Alexandra Johnson Wilcke
Cologny
Member of the board
Joint signing authority (any two to sign)
Urs Kunz
Baden
Joint signing authority (any two to sign)
Patrice Morin
Merion Station, US
Joint signing authority (any two to sign)
Nicolas Killen
Puplinge
Member of the board
Joint signing authority (any two to sign)
Jedd Wolchok
New York, US
Member of the board
Joint signing authority (any two to sign)
Chi Dang
Lutherville Timonium, US
Member of the board
Joint signing authority (any two to sign)
Edward McDermott
Westport, US
Chairperson of the board
Joint signing authority (any two to sign)
Xing Chen
Harrington Park, US
Member of the board
Joint signing authority (any two to sign)
Hans Notter
Jupiter, US
Vice-chairperson of the board
Joint signing authority (any two to sign)
John Gordan
New York, US
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | (Transfer) | (Transfer) | |||
| 2 | 36620 | 21.08.2024 | 164 | 26.08.2024 | 1006113628 |
| 3 | A36179 | 19.08.2024 | A162 | 22.08.2024 | 1006111496 |
| 4 | 35196 | 12.08.2024 | 157 | 15.08.2024 | 1006106912 |
| 5 | 27910 | 05.07.2023 | 131 | 10.07.2023 | 1005790734 |
| 6 | A26855 | 29.06.2023 | A127 | 04.07.2023 | 1005785385 |
| 7 | 18007 | 02.05.2023 | 87 | 05.05.2023 | 1005739031 |
| 8 | 37976 | 22.09.2022 | 187 | 27.09.2022 | 1005569556 |
| 9 | 32676 | 15.08.2022 | 159 | 18.08.2022 | 1005543137 |
| 10 | 30388 | 26.07.2022 | 146 | 29.07.2022 | 1005531653 |
Company Purpose
Unmittelbare, ständige und aktive Führung von medizinischer Forschung, insbesondere auf dem Gebiete des Krebses und anderer neoplastischer Krankheiten, zum Nutzen der Allgemeinheit in Verbindung mit einem oder mehreren Spitälern; usw.